Blood Lymphocyte-To-Monocyte Ratio Identifies High-Risk Patients in Diffuse Large B-Cell Lymphoma Treated With R-Chop

PLoS ONE - United States
doi 10.1371/journal.pone.0041658
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Multiplex Polymerase Chain Reaction-Based Prognostic Models in Diffuse Large B-Cell Lymphoma Patients Treated With R-Chop

British Journal of Haematology
Hematology
2016English

Diffuse Large B-Cell Lymphoma Presenting With Gastrocolic Fistula and Successfully Treated With R-Chop Chemotherapy

Tenri Medical Bulletin
2018English

Prognostic Impact of Tumor-Associated Macrophages, Lymphocyte-To-Monocyte and Neutrophil-To-Lymphocyte Ratio in Newly Diagnosed Diffuse Large B-Cell Lymphoma Patients

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Tumor Necrosis as a Prognostic Factor of Diffuse Large B-Cell Lymphoma Treated With R-Chop Therapy

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Prognostic Performance of Lymphocyte-To-Monocyte Ratio in Diffuse Large B-Cell Lymphoma: An Updated Meta-Analysis of Eleven Reports

OncoTargets and Therapy
OncologyPharmacology
2016English

The Derived Neutrophil to Lymphocyte Ratio Is an Independent Prognostic Factor in Patients With Diffuse Large B-Cell Lymphoma

British Journal of Cancer
Cancer ResearchOncology
2013English

Phase Ii Study of Durvalumab (Anti-Pd-L1) Combined With Either R-Chop or Lenalidomide and R-Chop in Previously Untreated, High-Risk Diffuse Large B-Cell Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

CD30 Expression in Diffuse Large B-Cell Lymphoma Correlates With Non-GCB Subtype but Does Not Have Prognostic Impact in Patients Treated With First Line R-Chop/R-Chop-Like

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

BCL-2 Protein Frequency in Patients With High-Risk Diffuse Large B-Cell Lymphoma

Sao Paulo Medical Journal
Medicine
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy